C92 Catégorie · précision supplémentaire requise Myeloid leukemia

ICD-10-CM C92 identifies “Myeloid leukemia” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapitre 2: Neoplasms

Instructions du code

Includes2
  • granulocytic leukemia
  • myelogenous leukemia
Excludes 11

personal history of leukemia (Z85.6)

Code also1

, if applicable, pancytopenia (acquired) (D61.818)

Instructions des niveaux supérieurs

Chapitres 2 · Neoplasms (C00-D49)

Note8
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

Excludes 24
  • Kaposi's sarcoma of lymph nodes (C46.3)
  • secondary and unspecified neoplasm of lymph nodes (C77.-)
  • secondary neoplasm of bone marrow (C79.52)
  • secondary neoplasm of spleen (C78.89)

Codes plus précis

Références de l’index officiel
Références depuis d’autres codes (1)
Historique

Historique du code

Dernière modification enregistrée · FY2024

ModifiéInchangé
FY2024

En vigueur dès le

  • Instructions du code modifiées

Myeloid leukemia

Catégorie — choisir un code plus précis

CDC/NCHS · FY2024

Toutes les éditions (19)

Toutes les éditionsEn vigueur dès leHistorique du code
FY20162015-10-01Première observation
FY20172016-10-01Aucun changement tabulaire
FY20182017-10-01Aucun changement tabulaire
FY20192018-10-01Aucun changement tabulaire
FY20202019-10-01Aucun changement tabulaire
FY2020 · April2020-04-01Aucun changement tabulaire
FY20212020-10-01Aucun changement tabulaire
FY2021 · 01-012021-01-01Aucun changement tabulaire
FY20222021-10-01Aucun changement tabulaire
FY2022 · 04-012022-04-01Aucun changement tabulaire
FY20232022-10-01Aucun changement tabulaire
FY2023 · 04-012023-04-01Aucun changement tabulaire
FY20242023-10-01Instructions du code modifiées
FY2024 · 04-012024-04-01Aucun changement tabulaire
FY20252024-10-01Aucun changement tabulaire
FY2025 · 04-012025-04-01Aucun changement tabulaire
FY20262025-10-01Aucun changement tabulaire
FY2026 · April2026-04-01Aucun changement tabulaire
FY20272026-10-01Aucun changement tabulaire

Explorez les codes plus précis de cette catégorie. La vérification du référentiel ne confirme pas la pertinence clinique et ne garantit pas le remboursement.